Cost-effectiveness of ALK testing and first-line crizotinib therapy for non-small-cell lung cancer in China
2018 ◽
Vol 13
(10)
◽
pp. e0205827
◽
Shun Lu
◽
Yongfeng Yu
◽
Shijun Fu
◽
Hongye Ren
Yong-Jin Kim
◽
Mark Oremus
◽
Helen H. Chen
◽
Thomas McFarlane
◽
Danielle Fearon
◽
...
2015 ◽
Vol 18
(3)
◽
pp. A203
2019 ◽
Vol 127
◽
pp. 84-89
◽
Xiaohua Gu
◽
Qiang Zhang
◽
Yun-Bo Chu
◽
Yi-Yang Zhao
◽
Yan-Jun Zhang
◽
...
2019 ◽
Vol 22
(4)
◽
pp. 344-349
◽
Weiting Liao
◽
Jiaxing Huang
◽
David Hutton
◽
Qiu Li
Huabin Hu
◽
Longjiang She
◽
Mengting Liao
◽
Yin Shi
◽
Linli Yao
◽
...
C. Chouaid
◽
L. Bensimon
◽
A. Millier
◽
E. Clay
◽
R. Insinga
◽
...
M.S. Holleman
◽
M.J. Al
◽
C.A. Uyl-de Groot
2010 ◽
Vol 13
(7)
◽
pp. A270
◽
J Jacob
◽
M Henriksson
◽
D Brattström
2018 ◽
Vol 4
(8)
◽
pp. 1080
◽
Pedro N. Aguiar
◽
Benjamin Haaland
◽
Wungki Park
◽
Pui San Tan
◽
Auro del Giglio
◽
...
E. Öksüz
◽
S. Malhan
◽
L. Yanik
◽
E. Koc
◽
E. Erdogan-Ciftci
◽
...